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Synthetic CT imagesa b s t r a c t
Background and purpose: Recent studies have shown that it is possible to conduct entire radiotherapy
treatment planning (RTP) workflow using only MR images. This study aims to develop a generalized
intensity-based method to generate synthetic CT (sCT) images from standard T2-weighted (T2w) MR
images of the pelvis.
Materials and methods: This study developed a generalized dual model HU conversion method to convert
standard T2w MR image intensity values to synthetic HU values, separately inside and outside of atlas-
segmented bone volume contour. The method was developed and evaluated with 20 and 35 prostate can-
cer patients, respectively. MR images with scanning sequences in clinical use were acquired with four dif-
ferent MR scanners of three vendors.
Results: For the generated synthetic CT (sCT) images of the 35 prostate patients, the mean (and maximal)
HU differences in soft and bony tissue volumes were 16 ± 6 HUs (34 HUs) and 46 ± 56 HUs (181 HUs),
respectively, against the true CT images. The average of the PTV mean dose difference in sCTs compared
to those in true CTs was 0.6 ± 0.4% (1.3%).
Conclusions: The study provides a generalized method for sCT creation from standard T2w images of the
pelvis. The method produced clinically acceptable dose calculation results for all the included scanners
and MR sequences.
 2017 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 125 (2017) 411–419Magnetic resonance imaging (MRI) has gained a major role in
radiotherapy target and organ-at-risk (OAR) delineation due to
its high soft tissue contrast and versatile nature [1–3]. The current
standard practice is to apply both MRI and computed tomography
(CT) for the radiotherapy treatment planning (RTP) workflow –
MRI for delineation, and CT for dose calculation and image-
guided radiotherapy (IGRT). This workflow is prone to possible
systematic errors when MR and CT images are co-registered for
transferring delineated contours to images used in dose calculation
and IGRT [4,5]. Omitting the CT scan and using an MRI-onlyapproach would minimize these systematic errors [6] and reduce
the number of planning scans hence increasing patient comfort,
saving time, and reducing need for clinical resources.
MR images do not contain electron density (ED) information
and therefore cannot be directly utilized for dose calculations.
The MRI-only workflow incorporates so-called synthetic CT (sCT)
images in which Hounsfield unit (HU) values are reconstructed
using only the original MR image. Recent studies have shown that
it is possible to perform entire RTP workflow, including image
guidance, using only MR images [1,7–13].
Several methods have been published for sCT image generation
[14]. Three main categories are: use of bulk densities [15,16], atlas-
based MR image registration to a model CT image [17,18] and
voxel-based intensity conversions [9,19]. The bulk density
412 MRI-only RT with standard T2w imagesapproach uses uniform HU values for large segmented volumes e.g.
whole body or bones. Atlas-based sCT construction utilizes co-
registered MR- and CT-images to transfer the HU values to an
MR image, whereas voxel-based methods rely on the original MR
image information (voxel intensity value or spatial location, etc.)
to transform the MR image intensity values to HU values. Some
sCT construction methods include combinations of the categories.
The dual model HU conversion method transforms MR image
intensity values of T1-weighted in-phase MR image directly to pre-
defined HU values separately inside and outside of an atlas-based
auto-contoured bone volume [9,20–22]. The method has been
applied for clinical MRI-only RTP protocol at the Cancer Center of
Helsinki University Central Hospital. Since 2012, the clinic has
treated nearly 400 prostate cancer patients with the MRI-only
workflow [1,9,10,23].
Direct MR intensity to HU value conversion is fast and easy to
adopt with various software. Conversion algorithm is iteration-
free, which enables HU conversion in roughly 30 s with our current
software and hardware setup. There is a potential to further opti-
mize the conversion to reach sub-second timescale.
Previous sCT studies have mainly evaluated the feasibility of
each method for only one MR scanner with particular imaging
parameters. In practice, manufacturer and scanner differences,
magnetic field strength, image acquisition and coil differences will
inevitably result in variations in MRI signals. Recently, Persson
et al. have studied prostate RTP dose calculation accuracy of
atlas-based sCTs produced via cloud-based conversion system
[24]. They presented a mean dose difference of 0.2 ± 0.4% in the
target with 145 patients with four different MR scanners. The pri-
mary aim of this study is to develop a generalized intensity-based
conversion method functioning with standard T2-weighted (T2w)
images acquired with scanners of different vendors, and with vari-
ety of imaging parameters. The generalized model is intended to
act as a backbone for adopting intensity-based conversion work-
flow for a specific scanner. MR images were obtained from four dif-
ferent clinics using their local imaging workflows. The work aims
to construct a robust clinically available workflow to be employed
with generic medical image processing software to automatically
perform both steps of the sCT generation method (bone segmenta-
tion and intensity conversion). The quality of the produced sCT
images should be independent from inter-patient, -scanner or -
clinic differences; e.g. patient size, absolute MR image intensity
values or coil positioning. The main focus was on prostate cancer,
for which T2w images are already used as standard target delin-
eation images, and thus potentially no extra sequences would be
needed for the MRI-only protocol.Table 1
Parameters of the used MR-sequences.
Scanner 1 Scanner
Scanner model GE Optima 1.5 T Philips I
Sequence type FSE T2w 3D TSE T2w
Echo time 97 ms 100 ms
Repetition time 1900 ms 9392 ms
Echo train length (ETL) 84 25
Bandwidth 355 Hz/pix 203 Hz/p
Acquisition matrix 448  448 500  50
Reconstruction matrix 512  512 768  76
Flip angle 90 90
Number of slices 72–124 60
Field-of-view 450  450 mm2 500  50
Pixel size 0.9 mm 0.7 mm
Slice thickness 2.4 mm 2.0 mm
Distance between slice centers 1.2 mm 3.0 mm
Patients for model creation 5 5
Patients for model evaluation 10 5
* Reconstruction matrix was reduced to 512  512 for data processing and sCT creatiMaterials and methods
Scanners and patient cohort
Four scanners from three different vendors – two with 1.5 T and
two with 3.0 T field strengths – were included in the study
(Table 1). Scanners are referred to by their arithmetic numeration
throughout the article. Four clinics from Finland, Sweden, Den-
mark, and Australia provided MR images for this study, all with
their individual choice of set-up, coils, sequences, and workflows.
Images obtained for the study were conventional T2-weighted
sequences in clinical use without any modifications made for this
study. Images were collected with large field-of-view (FOV), rang-
ing from 43 cm to 50 cm, to cover the whole-body contour.
Vendor-based gradient nonlinearity and intensity inhomogeneity
corrections were applied for the images. The study included a total
of 20 patients for model creation and 35 patients for model evalu-
ation. All the patient data were collected retrospectively and this
study had no effect on their treatment.Synthetic CT generation method
The dual model HU conversion method was used as a base for
the method presented in this study. The model has been described
earlier in detail [9,10,20–22]. In brief, the model consists of auto-
segmentation of the bone volume followed by conversion of MR
image intensities to HU values separately within and outside of
the bone contour. The dual model method features polynomial
and threshold-based conversions within and outside of bone seg-
ment, respectively. Initially a fourth-degree polynomial fit was
used for the bone volume MR image intensity values, accompanied
with fine tuning of the conversion curve for minimizing differences
on the whole HU scale. Polynomial was converted to step-wise
function with twenty segments to speed up the HU conversion
software. Soft tissue conversion relies on known HU values of adi-
pose tissue and muscle, and measured variance of the MR intensi-
ties in these tissues. The MR intensity values in between the two
tissue classes were linearly interpolated to HUs with step-wise
functions. In this study, corresponding MRI and CT intensity values
were collected using 2.5 and 5.0 mm diameter data collection
volume-of-interests (VOI) for the bony tissue and soft tissue
classes, respectively [9]. A rigid registration between the MR and
CT image volumes was made based on mutual information [9].
As the dual model method uses absolute MR image intensity
values, the feasibility of sCT generation is dependent on the overall
intensity level of the MR image. MR image intensity levels vary2 Scanner 3 Scanner 4
ngenia 1.5 T Siemens Skyra 3.0 T GE Discovery 3.0 T
2D FSE T2w 3D FSE T2w 2D
102 ms 102 ms
1200 ms 15,000 ms
80 15
ix 781 Hz/pix 390 Hz/pix
0 256  256 640  512
8 256  256 1024  1024*
135 130
128 88
0 mm2 430  430 mm2 448  448 mm2
1.6 mm 0.4 mm (0.9 mm*)
1.6 mm 2.5 mm





The differences between CT and sCT (CT-sCT) images regarding HU values and dose calculation results. Scanner-dependent scaling factors and background levels with relative
dose difference in OARs are presented. *Dose comparison results against standard CT images for scanner-specific conversion for scanner 3 are displayed in parentheses.
Scanner model Scanner 1 Scanner 2 Scanner 3* Scanner 4 All patients
GE Optima 1.5 T Philips Ingenia 1.5 T Siemens Skyra 3.0 T GE Discovery 3.0 T
Number of patients 10 5 10 10 35
Mean diff. ± SD Soft tissue (HUs) 16 ± 7 20 ± 8 18 ± 3 13 ± 6 16 ± 6
Bone (HUs) 79 ± 41 91 ± 32 14 ± 22 51 ± 1 46 ± 56
Dose Mean diff. ± SD (%) 0.5 ± 0.4 0.5 ± 0.2 0.9 ± 0.2 (0.2 ± 0.1) 0.4 ± 0.2 0.6 ± 0.4
V5% 0.3 ± 0.4 0.3 ± 0.2 0.8 ± 0.2 (0.1 ± 0.1) 0.3 ± 0.2 0.4 ± 0.4
V95% 0.6 ± 0.3 0.5 ± 0.2 1.0 ± 0.2 (0.4 ± 0.1) 0.5 ± 0.2 0.7 ± 0.3
Scaling factor (mean & SD) 0.47 ± 0.06 2.96 ± 0.15 1.27 ± 0.12 0.21 ± 0.02 –
Background reduction (value & SD) 28 ± 3 6 ± 1 0 ± 0 374 ± 54 –
OAR dose difference (%)
Mean dose
Rectum 0.1 ± 0.2 0.2 ± 0.1 0.3 ± 0.05 (0.1 ± 0.04) 0.1 ± 0.1 0.19 ± 0.13
Bladder 0.2 ± 0.1 0.2 ± 0.03 0.3 ± 0.1 (0.2 ± 0.1) 0.2 ± 0.1 0.24 ± 0.09
Femoral head (left) 0.1 ± 0.1 0.1 ± 0.1 0.3 ± 0.1 (0.1 ± 0.1) 0.2 ± 0.1 0.19 ± 0.11
Femoral head (right) 0.2 ± 0.1 0.1 ± 0.04 0.3 ± 0.1 (0.1 ± 0.1) 0.2 ± 0.1 0.19 ± 0.11
DVH (%)
Rectum (V40%) 0.1 ± 0.4 0.3 ± 0.2 0.3 ± 0.1 (0.2 ± 0.1) 0.3 ± 0.2 0.24 ± 0.23
Bladder (V40%) 0.2 ± 0.1 0.2 ± 0.1 0.2 ± 0.1 (0.1 ± 0.1) 0.1 ± 0.1 0.17 ± 0.11
Femoral head (left, V20%) 0.5 ± 0.5 0.7 ± 0.7 1.4 ± 0.8 (0.5 ± 0.5) 0.7 ± 0.4 0.84 ± 0.73
Femoral head (right, V20%) 0.7 ± 0.3 0.5 ± 0.3 1.2 ± 0.8 (0.5 ± 0.3) 0.8 ± 0.9 0.83 ± 0.68
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similar pulse sequence [25,26]. There is no standardization of MR
intensities as in CT numbers [27].
Therefore, in this study, we developed a generalized method
which is not affected by the absolute MR intensity levels. The gen-
eralized method incorporates a scaling of the original MR intensi-
ties to a base level, followed by the MR intensity value to HU
value conversion with the dual model method.
The scaling of the intensity levels of MR images was performed
by removing the background noise signal level – measured from
cortical bone near isocenter using 20 VOIs with 2.5 mm diameter
– and scaling all MR image intensity values linearly according to
the absolute MR image intensity of the adipose tissue near the
isocenter – collected with 20 VOIs with 5 mm diameter. The pro-
cess is described in Eq. (1):
Ifinal ¼ ðIoriginal  bÞ  kaveragek ð1Þ
where I is the intensity of a given voxel for a patient before and after
scaling, b is the background noise signal value, kaverage represents
the average base value of the adipose tissue of all the 20 patients
in model creation group, and k is the intensity value of adipose tis-
sue of a particular patient. The adoption of adipose tissue MR inten-
sity values near the isocenter was considered optimal to minimize
influence of image intensity inhomogeneities (intra-patient varia-
tions) on conversion accuracy, and to define general intensity level
of a particular image (inter-patient variations). The base value to
which all images were scaled was an intensity value of 200. This
value was an approximate mean intensity level of the adipose tissue
near the isocenter of all 20 images.
These scaling values (kaverage/k) varied considerably among plat-
forms and the factors that were used are presented in Table 2. Con-
version curves for the model were created according to the scaled
data collection VOIs and were divided into twenty-one and nine
intensity intervals for HU value conversion for bony and soft tissue
volumes, respectively, seen in the Fig. 1c) and d) as step functions.
Additionally, the study included scanner-specific conversion mod-
els, and evaluated potential improvements on sCT construction by
using those instead of applying the developed general model.
Atlas-based auto-segmentation for the bone contours was con-
ducted using commercial image processing software MIM v6.5.5
(MIM Software, Inc., Cleveland, OH, USA). Five patients of the
scanner 1 patient group were incorporated in the bone atlas #1.Auto-segmentation method of 5/5 was used; five patients were
used in the auto-segmentation process of the total five patients
present in the atlas. Scanner 1 bone atlas #1 was also used for con-
touring scanner 2 images. Original scanner 2 images were scaled to
match average intensity level of scanner 1 images and then auto-
contoured using bone atlas #1 with scanner 1 images. This was
done to demonstrate the feasibility of using standard T2w images
across scanner platforms for the atlas-based auto-segmentation.
Bone contours for scanner 3 patients were contoured with the
multi-atlas/local weighted voting auto-segmentation method
applied by Dowling et al [11]. Scanner 4 images were contoured
similarly to scanner 1, as 5/5 method was used with scanner 4
images in the atlas. Different contouring approaches were selected
to point out that any well-functioning auto-segmentation work-
flow is compatible with the generalized dual model method.
No manual contouring was done after auto-segmentation for
evaluating feasibility of the fast, clinical approach of the segmenta-
tion. Previous studies have shown that, the automatic atlas-based
bone segmentation enables precise sCT generation and accurate
dose calculation in the pelvic region [11,18] (0.1 ± 0.1% dose differ-
ences in the prostate PTV compared to those with manually pre-
cisely contoured bones [21]). The exterior body contour of the CT
image was used in the sCT instead of the MR image body contour
to minimize the dose calculation differences arising from altered
posture between CT and MR imaging. The time frame between
CT and MR acquisitions varied fromminutes to days among the dif-
ferent clinics, creating inevitable changes to patient anatomy and
skin position. Prior et al [28] have concluded that ignoring body
outline changes can result up to several percent dose difference
between CT and sCT images. Additionally, one of the MR scanners
was not equipped with a flat table top. The presented workflow of
MR intensity scaling and dual model HU value conversion was then
repeated for the 35 prostate cancer patients in the evaluation
group using the model created from the group of 20 different
patients. Conversion time from MR image intensity values to HU
values was approximately 30 s for each patient with standard
quad-core desktop computer.Evaluation of sCT image quality and dose calculation accuracy
Resulting HU values were compared against the CT image HU
values by calculating the mean values for the soft and bony tissue
volumes, and calculating the difference as CT-sCT. Treatment
Fig. 1. The CT image HU values with corresponding MR image intensity values in soft tissue (a, c) and bony tissue (b, d) segments. In subfigures (a) and (b) are the original,
raw MR image intensity values for each scanner and subfigures (c) and (d) presents the MR image intensity values after background reduction and intensity scaling with the
step functions of the conversions overlaid (thick line represents the general model and dashed lines correspond to the scanner-specific conversion curves).
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therapy (VMAT) using 10 MV photons. Plans were optimized and
calculated on the sCT images and then copied to CT images and
re-calculated. Dose calculation was conducted using the anisotro-
pic analytical algorithm (AAA 13.6.23, Varian Medical Systems,
Palo Alto, USA) with grid size of 0.1 cm. Dose comparisons were
conducted by calculating differences in dose volume histogram
(DVH) parameters between sCT and CT for the PTV (mean, V5,
V95), OARs (rectum & bladder [mean, V40%] and femoral heads
[mean, V20%]). Contouring of the OARs was done on the MR image
and then copied to the CT image – this workflow enables a better
approximation of the dose differences in DVH analysis considering
the OAR volume variation e.g. bladder filling. Analysis of variance
(ANOVA) was conducted with SPSS (IBM Corp. Released 2013.
IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM
Corp.) to study the differences between scanners.Results
Fig. 1 presents CT image HU values with corresponding MR
image intensity values from the data collection VOIs of the 20-
patient model creation group. Variation of original MR intensity
values between the scanners can be seen in Fig. 1a) and b) for soft
and bony tissues, respectively. Reduced variance after background
reduction and intensity scaling is presented in Fig. 1c) and d). Soft
tissue conversion incorporated muscle and adipose tissue HU val-
ues but omitted urine due to partial overlap with adipose tissueFig. 2. Transversal images of the produced sCT images (e–h) with original MR images (a–
4 (GE Discovery 3.0 T) and corresponding CT images (i–l). Dose difference maps (CT-sCT
scanner-specific sCT conversion result and dose. Scanner-dependent intensity windows u
intensity levels. Intensity windowing for the CT and sCT images is 300 to 600 HUs. MR im
Due to this and differences in vendor-specific image reconstruction, the high backgrounon the MR intensity scale with two sequences, hence urine was
converted mainly to adipose tissue HU values, see Fig. 1c).
Scanner-specific conversion curves in Fig. 1c) and 1d) provide com-
parison to the average conversion curve used for sCT creation.
Fig. 2 shows example images of the generated sCTs with corre-
sponding MR and CT images accompanied by dose difference maps.
Fig. 2e–h) shows example sCTs constructed by the generalized
model, and Fig. 2o) presents a scanner-specific sCT (Scanner 3).
The variation of the MR intensity values is demonstrated by
scanner-specific intensity windows used in image reconstruction
for visualization purposes. Table 2 presents results of the HU value
and dose calculation comparisons between CT and sCT images of
the 35-patient evaluation group. Mean whole soft tissue volume
HU differences (CT-sCT) ranged from 13 to 20 HUs between scan-
ners and mean whole bony tissue volume HU differences from
91 to 14 HUs. The largest average HU value difference was 34
HUs in soft tissue and 181 HUs in bony tissue segment. Intensity
value scaling factors ranged from 0.18 to 3.17 in all scanners, but
within each scanner the largest variation remained within 24% or
lower compared to the mean scaling value of that scanner. The
average of the PTV mean dose difference for all 35 patients in the
evaluation group was 0.6% with SD of 0.4% (range: 0.1% to
1.3%), and DVH point differences for V5 and V95 were 0.4 ±
0.4% and 0.7 ± 0.3%, respectively. The mean PTV dose difference
for scanner-specific sCTs was 0.2 ± 0.1% with DVH point differ-
ences of 0.1 ± 0.1% and 0.4 ± 0.1% for V5 and V95, respectively.
The largest individual patient dose difference for the mean PTV
dose was 1.3% and the largest single-voxel point dose differenced) by scanners 1 (GE Optima 1.5 T), 2 (Philips Ingenia 1.5 T), 3 (Siemens Skyra 3.0 T),
dose) are presented for corresponding cases (m–p) – *scanner 3 is presented with
sed in this figure are presented for each MR image indicating variation of the original
age intensity values (a–d) are presented linearly from 0 to a given maximum value.
d noise in the air is clearly visualized in the image d.
416 MRI-only RT with standard T2w imageswas 1.7%, 1.9%, 1.9%, and 1.8% for Scanners 1, 2, 3, and 4,
respectively. Dose comparison of the generalized sCTs for OAR vol-
ume mean dose differences resulted in 0.2 ± 0.1% difference for
all specified structures (rectum, bladder, left and right femoral
head) with average DVH point differences smaller than 1%. Com-
prehensive OAR dose calculation results can be found in Table 2.
Fig. 3 presents orthogonal reconstructions of the CT (a–c) images,Fig. 3. Transversal (a, d, g), coronal (b, e, h) and sagittal (c, f, i) slices of CT and sCT images
d–f shows the scanner-specific conversion sCTs. Dose comparison maps of a scanner-spe
(m–o), respectively. In this case the mean PTV dose difference was 0.2% for the scanne
mainly in bone volumes (see coronal images) between averaged and scanner-specific m
some bone edges (e.g. acetabulum).scanner-specific conversion sCT (d–f) results with corresponding
generalized sCT (g–i) – Dose comparison maps of a scanner-
specific and generalized method against the CT image are found
in subfigures (j–l) and (m–o), respectively.
ANOVA-analysis of the dose difference results for PTV mean
doses shows that there is a significant (p = 0.025) variation
between the scanners when using the generalized model.for the scanner 3. Subfigures g–i represents the result with generalized method and
cific and generalized method against the CT image are found in subfigures (j–l) and
r-specific and 0.8% for the generic method. Differences in HU values can be seen
odels. Minor mm-scale imperfections of the bone auto-segmentation can be seen in
Table 3
Statistical analysis of the PTV mean dose differences between scanners with least
significant difference (LSD) for the generalized model, p-values <0.05 are presented in
bold.
p-Values of the scanner-to-scanner comparison
Scanners 1 2 3 4
1 0.911 0.012 0.946
2 0.911 0.028 0.956
3 0.012 0.028 0.010
4 0.946 0.956 0.010
L. Koivula et al. / Radiotherapy and Oncology 125 (2017) 411–419 417Comparison between the scanners using least significance differ-
ence (LSD) reveals that scanner 3 sCTs varies significantly from
the other three scanners – results are presented in Table 3. No sig-
nificant differences were found between scanners 1, 2, and 4.Discussion
This study presented an automatic intensity-based sCT con-
struction method for standard T2w images of the pelvis. The
method was tested for multiple MRI platforms with variable imag-
ing parameters, thus demonstrating the generalizability and
robustness of the method for MRI-only RTP. The produced hetero-
geneous sCTs enabled clinically acceptable dose calculation accu-
racy. Overall dosimetric agreement in the prostate PTV was 0.6
± 0.4% [range: 0.1 to 1.3%]. This is a comparable result with
other previously published high quality sCTs [9–11,21,24,29–31].
Persson et al. [24] have presented mean PTV dose difference of
0.2 ± 0.4% [range: 1.3 to 0.7%] without body outline correction
and approximately 0.1 ± 0.2% [range: 0.5 to 0.6%] with body con-
tour correction. Dowling et al. [11] presented PTV DVH V50% 0.5
± 1.1% [quartiles (25, 75%) 0.0 to 1.4%]. Korhonen et al [9] have
previously shown a PTV DVH V50% difference of 0.3 ± 0.2% [range:
0.0–0.8%].
The presented generalized conversion method provided exten-
sive functionality despite the variation between different clinic’s
scanning workflows and MR images. The HU accuracy in the gen-
erated sCTs was roughly at a similar level to previously developed
sCT methods. However, this generalized method included higher
HU uncertainties compared to methods developed particularly
for a specific sequence [9,11,18,32,19,22]. Scanner-specific conver-
sion curves for sCT creation resulted in smaller mean PTV dose dif-
ferences (0.9 ± 0.2% vs. 0.2 ± 0.1%) for the Scanner 3 images.
Generalized model provided an average PTV dose difference of
0.5% or smaller in sCTs for all other scanners. All four scanners
resulted in a PTV mean dose difference smaller than 1.3% with
the generic method demonstrating the clinical feasibility – with
scanner-specific conversion method the dose difference approach
negligible values. The generalized method presents a model and
an example of the HU conversion workflow for standard T2-
weighted MR images that can easily be adopted in other clinics.
The collection of scanner-specific MR intensity values is encour-
aged when commissioning the MRI-only conversion protocol. Vari-
ation between scanner 3 and the other scanners was caused mainly
by the MR intensity variation of the spongy bone. As the general-
ized model uses averages of multiple scanners, it cannot account
for any exceptional variations from one scanner and intensity level.
Precise determination of the accuracy of the sCT conversion is dif-
ficult due to other confounding factors that influence the dose dif-
ferences including anatomical differences between consecutive
scans [28] and the inherent HU value uncertainty in CT images
(e.g. HU accuracy, HU-to-ED calibration, artifacts) [33,34].
The generalized method produced a small systematic error in
the mean difference of the soft tissue HU values and in the mean
PTV doses between CT and sCT images. The sCT images presentedsystematically lower soft tissue HUs with respectively higher dose
in the target region, due to lower attenuation of the photon beam.
As the applied RT plan was a full-arc VMAT, the HU value accuracy
of the soft tissue volume has a relatively high effect on the dose
distribution compared to plans containing mainly lateral beams
through the femoral heads. There are several reasons for the
observed results. As the method converts MR intensity values
directly to HUs, soft tissue structures with high HU (0–50) and high
MR signal are intrinsically misrepresented as adipose tissue. Such
structures are for example bulbus penis, some blood vessels and
nerves, seminal vesicles, and malignant prostate tissue with addi-
tion to all tissues containing liquid in a macroscopic scale. Higher
HU values in bony tissue might be explained by the simplicity of
the utilized polynomial fitting for the data. Furthermore, the fitting
does not evaluate volumetric differences between bone structures
(cortical bone, spongy bone, bone marrow) but includes only the
intensity value data for the conversion model generation.
Fig. 1d) shows the largest variation of the conversion curves on
the HU scale of 100–600 HUs, which corresponds mainly to the
spongy bone volume. Correspondingly, the largest difference on
the dose distribution of the OARs can be found in the femoral heads
– an average difference of DVH point V20% for all four scanners was
0.8 ± 0.7% and for scanner 3 1.3 ± 0.8%. The scanner-specific sCT
reconstruction for scanner 3 resulted in smaller error and variation
of the dose in femoral heads (average of 0.5 ± 0.4%) as well in
other OARs and PTV.
The MR image intensity inhomogeneity and functionality of the
HU conversion could have a substantial effect on the dose distribu-
tion [8], as femoral heads incorporate a relatively large volume
near the prostate. Thus, future studies could aim to further
improve the model especially for spongy bones. Difference
between sCTs with scanner-specific or generalized model for scan-
ner 3 can be seen in the coronal images of the Fig. 3. Conversion of
the soft tissue volume is almost invariant of the conversion
method, but a noticeable difference is present in some parts of
the bone volume.
The conversion method did not incorporate urine in the prede-
fined HU values as there was an overlap of the signals for scanner 3
and 4, and it would have mislabeled large volumes of adipose tis-
sue as water, even though sequences used with scanners 1 and 2
would have enabled the separation of adipose tissue and urine
on the MRI intensity scale. Tuning the sequence parameters, e.g.
the flip angle and echo train length (ETL), might enable better sep-
aration between different tissue classes on the MR image and
hence result in more accurate heterogeneous sCT image. Including
urine/water HU values in the conversion method would enable the
conversion of high signal MRI voxels to water equivalent instead of
adipose tissue, hence improving the overall HU equivalency. Pre-
cise conversion of urine for sCTs is not essential for MRI-only RTP
of prostate cancer patients.
Homogeneity of MR image intensity level across the whole
patient body volume is advantageous to obtain high quality
intensity-based sCT conversion. The MR image inhomogeneity cor-
rection algorithms are of particular value. Such algorithms are
standard in MR platforms and commercial image processing soft-
ware [35,36].
The presented method relies only on the absolute values of the
MR images, so possible changes in intensity homogeneity and
image artifacts could affect the resulting sCT image. Additionally,
the selected background reduction and scaling factor values inher-
ently influence the assigned HU values. Further validation and ver-
ification processes could assist in developing the most optimal
method for the scaling factor selection for the implementation into
the clinical MRI-only workflow.
Geometric distortions can restrict the use of MRI in RT.
Geometrical distortions stemming from system related effects such
418 MRI-only RT with standard T2w imagesas gradient non-linearity or B0 field inhomogeneities should be
evaluated before introducing a clinical MRI-only workflow [37].
Additional artifacts can derive from patient induced distortions,
such as susceptibility and chemical shift. Previous studies have
shown that with geometric accuracy better than 2 mm within
the entire FOV it is possible to achieve clinically feasible dose cal-
culation accuracy for MRI-only RTP [21,23,38–41]. The geometric
accuracy of the applied MR platforms was sufficient for MRI-only
RT [10,11,21,23,37].
An MRI-only approach is feasible and utilized internationally in
few clinics for radiotherapy of the prostate employing either com-
mercial or in-house sCT techniques. This study further advances
and support future research and clinical implementation of MRI-
only RTP by presenting a robust and practical synthetic CT conver-
sion workflow for standard T2-weighted MR images.
Conclusions
This study introduced a generalized dual model HU conversion
method to obtain high quality sCTs from standard T2-weighted MR
images. The method was shown to be suitable for images acquired
with different MR platforms of different vendors. The work pre-
sented has demonstrated that using the obtained sCTs it is possible
to reach clinically feasible dose calculation accuracy for MRI-only
RT of prostate cancer patients. The generalized conversion work-
flow serves as the core component enabling commissioning of
MRI-only workflow in a particular clinic. The generalized method
produced sCT images with clinically feasible dose calculation accu-
racy despite of inter-patient, -scanner and -clinic differences. The
sCTs with scanner-specific conversion workflow presented similar
dose distribution as in standard CT images. Fine tuning of the MR
sequence parameters and HU conversion model could further
improve the sCT quality and dose calculation accuracy.
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